Literature DB >> 26260111

Amyloid-β induced astrocytosis and astrocyte death: Implication of FoxO3a-Bim-caspase3 death signaling.

Pampa Saha1, Subhas Chandra Biswas2.   

Abstract

Astrocytes, the main element of the homeostatic system in the brain, are affected in various neurological conditions including Alzheimer's disease (AD). A common astrocytic reaction in pathological state is known as astrocytosis which is characterized by a specific change in astrocyte shape due to cytoskeletal remodeling, cytokine secretion and cellular proliferation. Astrocytes also undergo apoptosis in various neurological conditions or in response to toxic insults. AD is pathologically characterized by progressive deposition of amyloid-β (Aβ) in senile plaques, intraneuronal neurofibrillary tangles, synaptic dysfunction and neuron death. Astrocytosis and astrocyte death have been reported in AD brain as well as in response to Aβ in vitro. However, how astrocytes undergo both proliferation and death in response to Aβ remains elusive. In this study, we used primary cultures of cortical astrocytes and exposed them to various doses of oligomeric Aβ. We found that cultured astrocytes proliferate and manifest all signs of astrocytosis at a low dose of Aβ. However, at high dose of Aβ the activated astrocytes undergo apoptosis. Astrocytosis was also noticed in vivo in response to Aβ in the rat brain. Next, we investigated the mechanism of astrocyte apoptosis in response to a high dose of Aβ. We found that death of astrocyte induced by Aβ requires a set of molecules that are instrumental for neuron death in response to Aβ. It involves activation of Forkhead transcription factor Foxo3a, induction of its pro-apoptotic target Bim and activation of its downstream molecule, caspase3. Hence, this study demonstrates that the concentration of Aβ decides whether astrocytes do proliferate or undergo apoptosis via a mechanism that is required for neuron death.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Apoptosis; Astrogliosis; Glia

Mesh:

Substances:

Year:  2015        PMID: 26260111     DOI: 10.1016/j.mcn.2015.08.002

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  14 in total

Review 1.  Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2017       Impact factor: 1.990

Review 2.  Astrocyte and Alzheimer's disease.

Authors:  Zhiyou Cai; Cheng-Qun Wan; Zhou Liu
Journal:  J Neurol       Date:  2017-08-18       Impact factor: 4.849

Review 3.  Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2018       Impact factor: 1.990

4.  Forkhead transcription factors: new considerations for alzheimer's disease and dementia.

Authors:  Kenneth Maiese
Journal:  J Transl Sci       Date:  2016-06-14

5.  Role and regulation of Cdc25A phosphatase in neuron death induced by NGF deprivation or β-amyloid.

Authors:  Nandini Chatterjee; Priyankar Sanphui; Stav Kemeny; Lloyd A Greene; Subhas C Biswas
Journal:  Cell Death Discov       Date:  2016-12-12

6.  Non-aggregated Aβ25-35 Upregulates Primary Astrocyte Proliferation In Vitro.

Authors:  Elise C Ohki; Thomas J Langan; Kyla R Rodgers; Richard C Chou
Journal:  Front Cell Neurosci       Date:  2017-09-26       Impact factor: 5.505

7.  The contribution of S100B to the glioprotective effects of valproic and arundic acids.

Authors:  Mojtaba Keshavarz; Majid Reza Farrokhi; Atena Amiri; Mahshid Hosseini
Journal:  Iran J Basic Med Sci       Date:  2019-05       Impact factor: 2.699

8.  A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma.

Authors:  Stefan Salcher; Gilles Spoden; Judith Hagenbuchner; Sebastian Führer; Teresa Kaserer; Martin Tollinger; Petra Huber-Cantonati; Thomas Gruber; Daniela Schuster; Ronald Gust; Heinz Zwierzina; Thomas Müller; Ursula Kiechl-Kohlendorfer; Michael J Ausserlechner; Petra Obexer
Journal:  Oncogene       Date:  2019-10-07       Impact factor: 9.867

9.  Genetic targeting of astrocytes to combat neurodegenerative disease.

Authors:  Rachel Kery; Allen P F Chen; Gregory W Kirschen
Journal:  Neural Regen Res       Date:  2020-02       Impact factor: 5.135

10.  Isoforsythiaside Attenuates Alzheimer's Disease via Regulating Mitochondrial Function Through the PI3K/AKT Pathway.

Authors:  Chunyue Wang; Jie Hao; Xin Liu; Chenliang Li; Xuyang Yuan; Robert J Lee; Tian Bai; Di Wang
Journal:  Int J Mol Sci       Date:  2020-08-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.